Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Infect Control ; 16(4): 141-6, 1988 Aug.
Article in English | MEDLINE | ID: mdl-3263821

ABSTRACT

Retrospective review of 197 patients with methicillin-resistant Staphylococcus aureus (MRSA) identified 47 in whom a regimen for eradication of MRSA colonization could be evaluated. The patients were elderly (mean age, 67.7 years), with 53% transferred from another institution and 53% treated in an intensive care unit. A mean of 47.1 days of hospitalization with an average of 4.9 antibiotics preceded the first MRSA culture. The usual regimen (mean, 6.0 days) was oral trimethoprim-sulfamethoxazole, 160/800 mg twice daily, oral rifampin, 600 mg once daily, and bacitracin ointment three times a day. Eradication succeeded in 40 patients, 9 relapsed, and MRSA persisted in 7. Twenty-four of 25 nares sites were cleared but only 16 of 22 other sites. MRSA infection eventually developed in 36%. No adverse reactions to the eradication regimen were noted. Although this treatment for MRSA carriage was safe and effective, decreased efficacy outside the nares and relapse limited its value.


Subject(s)
Bacitracin/therapeutic use , Cross Infection/prevention & control , Rifampin/therapeutic use , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Sulfamethoxazole/therapeutic use , Trimethoprim/therapeutic use , Aged , Carrier State/drug therapy , Drug Combinations/therapeutic use , Drug Therapy, Combination/therapeutic use , Hospital Bed Capacity, 300 to 499 , Humans , Methicillin/pharmacology , Middle Aged , Nebraska , Penicillin Resistance , Retrospective Studies , Staphylococcus aureus/isolation & purification , Trimethoprim, Sulfamethoxazole Drug Combination
SELECTION OF CITATIONS
SEARCH DETAIL
...